In a landmark move set to revolutionize cancer treatment in India, Kolhapur Cancer Centre (KCC) has signed a Memorandum of Understanding (MOU) with the renowned Cancer Centers of America (CCA), opening doors to global collaboration and cutting-edge medical expertise.

The agreement was signed at the KCC campus by Dr. Suraj Pawar, Chairman and Managing Director of KCC, and Rajesh Manthena, Executive Director and Chief Development Officer of CCA. This strategic partnership is expected to enhance the quality, accessibility, and technological edge of cancer care not only for Indian patients but also for international medical travelers.

With an impressive track record of treating over 50,000 patients across Western Maharashtra, Karnataka, and Goa, KCC caught the attention of CCA, known worldwide for its innovation and excellence in oncology. The collaboration aims to merge international standards with localized care, offering advanced treatment protocols, expert training, and patient-focused services.

Also Read: Musk’s Retweets Fuel Far-Right Surge in Europe

Dr. Shalin Shah, Chairman of the Board at CCA, joined virtually to extend his support, while the event saw the participation of KCC’s Executive Director Dr. Reshma Pawar and a host of senior oncologists and medical staff.

Patients in India will now gain access to CCA's advanced technologies and healthcare models, bringing hope closer to home for thousands battling cancer. The partnership underscores a joint commitment to compassionate, evidence-based, and highly effective cancer care.

This historic alliance marks a significant step in bridging the gap between global expertise and regional healthcare, making Kolhapur a new hub for world-class oncology.

Also Read: Mathura Man Shoots Wife, Kills Himself in Domestic Dispute